Cumberland Pharmaceuticals
Price & Volume
Stats
See moreOpen | $4.23 |
Previous Close | $4.19 |
Day Range | $4.10-$4.34 |
52W Range | $1.85-$6.26 |
Market Cap | $62.9M |
Shares Short | 112,896 |
Financials
See moreRevenue (12 Mos) | $44.5M |
Revenue Growth (YoY) | 31.1% |
Gross Profit (12 Mos) | $37.8M |
Diluted EPS | -$0.19 |
News
See moreYahoo Finance • 2 months ago
Cumberland (CPIX) Q4 2025 Earnings Call Transcript
Yahoo Finance • 2 months ago
Cumberland Pharmaceuticals Non-GAAP EPS of $0.11, revenue of $44.5M
Yahoo Finance • 2 months ago
Least shorted stocks with up to $2B market cap as of mid-February
Yahoo Finance • 6 months ago
Cumberland outlines new product expansion and sees $8.3M Q3 revenues while advancing clinical pipeline
About
CEO | Mr. A. J. Kazimi MBA |
CFO | Mr. John Michael Hamm C.M.A. |
Address | 1600 West End Avenue, Nashville, TN, United States, 37203 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 93 |